🇮🇹 Nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini
28 Jun, 2021
UniversitĂ degli Studi di Padova, Istituto Zooprofilattico Sperimentale delle Venezie e Penta presentano nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini Uno studio pubblicato in questi giorni…
Read More
🇮🇹 NeoIPC: strategie di prevenzione e di controllo delle infezioni neonatali
15 Jun, 2021
Parte da Padova il progetto europeo NeoIPC, che mira a ridurre le infezioni e la trasmissione di batteri resistenti nelle unitĂ di terapia intensiva neonatale. Padova, 15 giugno 2021 –…
Read More
🇬🇧 NeoIPC: a new project to improve prevention and control of infections in newborns
19 May, 2021
NeoIPC, a project seeking to reduce the transmission of resistant bacteria in neonatal intensive care units, has just launched.
Read More
🇮🇹 CORONA: bambini e COVID-19
21 Apr, 2021
Un progetto a guida italiana sostenuto da UniCredit Foundation Padova, 21 Aprile 2021 – Parte il progetto CORONA: bambini e COVID-19, sostenuto da UniCredit Foundation e condotto dalla Fondazione Penta di…
Read More
🇬🇧 CORONA: children and COVID-19
21 Apr, 2021
An Italian-led project supported by the UniCredit Foundation to study the impact of the coronavirus on children.
Read More
🇬🇧 New European-African collaboration to develop UNIVERSAL treatments for children living with HIV
03 Feb, 2021
Today marks the official launch of UNIVERSAL, the newly funded European-African clinical research partnership that aims to develop two antiretroviral formulations for children living with HIV and to speed up…
Read More
🇬🇧 PREPARE activated to Mode 2 in response to novel Coronavirus cases in Europe
06 Feb, 2020
On 30th January 2020, the Director General of the World Health Organisation (WHO) declared the outbreak of 2019-nCoV a public health emergency of international concern. In his statement, Dr Tedros…
Read More
🇬🇧 GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR
01 Apr, 2019
Geneva / Padova, Monday 4 March 2019 – The Global Antibiotic Research & Development Partnership (GARDP) and Penta, the paediatric infectious diseases research network, have joined forces to tackle drug-resistant…
Read More
🇬🇧 University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics
01 Apr, 2019
Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 The University of Antwerp, bioMĂ©rieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative…
Read More